SARS-CoV-2 neutralising antibodiesBiomarker1 paperHuman trial1LatestNov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 1Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 monthsAging Cell·May 22Spermidine Mitigates Immune Cell Senescence and Boosts Vaccine Responses in Healthy Older Adults-A Pilot StudyRandomized trial in 40 peopleSpermidinePapermedRxiv·May 30SARS-CoV-2 neutralising antibody activity in a highly vaccinated population: Longitudinal serology studies in SingaporePreprint: study in peoplePopulationsPaper
Aging Cell·May 22Spermidine Mitigates Immune Cell Senescence and Boosts Vaccine Responses in Healthy Older Adults-A Pilot StudyRandomized trial in 40 peopleSpermidinePaper
medRxiv·May 30SARS-CoV-2 neutralising antibody activity in a highly vaccinated population: Longitudinal serology studies in SingaporePreprint: study in peoplePopulationsPaper